Download PDFPDF

Is it time to consider rationalising IFN-β treatment in individuals with multiple sclerosis?
Free
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address